CFTR and cystic fibrosis: A new therapeutic strategy for CF involves cytoplasmic delivery of Locked Nucleic Acid (LNA)-modified RNA oligonucleotides custom-designed to block endogenous miRNAs binding to their cognate miRNA recognition elements (MREs) in the 3′ untranslated region (UTR) of the CFTR messenger RNA.